Insurance Claim Denial Management

Prepared: February 20, 2026 Data vintage: Primarily 2023-2025 sources (from analyst training data; live web verification was unavailable) Caveat: WebSearch and WebFetch tools were blocked during this session. All figures below are drawn from the analyst's training corpus (cut-off May 2025) and cite the original publication sources. Numbers should be independently verified before use in investment memos.

Author: Rigid Body Dynamics

1. PROBLEM MARKET SIZE

Revenue at Risk from Claim Denials

Cost Hospitals Spend on Denial Management

Bottom line: Denials put $150B-225B of hospital revenue at risk annually. Hospitals collectively spend $20B+ fighting them, and still write off $20B-45B.

---

2. CURRENT SPEND TO MANAGE

Revenue Cycle Management (RCM) Software Market

Note: The broader RCM market includes outsourced services, not just software. The software-only segment is a subset (~$20-25B in 2024).

Denial Management Software (Sub-Segment)

Medical Billing Outsourcing Market

---

3. COST OF INACTION

Key insight: More than half of denied claims are never contested, yet when hospitals do appeal, they win 50-70% of the time. This represents a massive recoverable revenue pool that is abandoned due to operational capacity constraints.

---

4. VOLUME FREQUENCY

---

5. WHY STILL UNSOLVED

Despite billions invested in RCM technology, denial rates have risen ~23% over the past decade (Change Healthcare Index, 2024). Key structural reasons:

5.1 Payer Algorithm Changes (Moving Target Problem)

• Insurers continuously update clinical criteria, coverage policies, and prior auth rules
• Medicare Advantage plans use proprietary AI/ML algorithms to auto-adjudicate (and auto-deny) claims
• OIG found MA plans denied 13-18% of prior auths, many of which met Medicare coverage criteria
• Payer rule changes outpace provider RCM software update cycles

5.2 Coding Complexity Explosion

• ICD-10 has ~72,000 diagnosis codes vs. ~14,000 in ICD-9
• CPT code updates annually (300+ changes/year)
• Modifier requirements increasingly complex
• Clinical documentation must precisely match coding requirements

5.3 Staff Turnover and Workforce Crisis

• Medical coder/biller turnover: 25-40% annually (AAPC 2024 salary survey)
• Average time to train a denial management specialist: 6-12 months
• Post-COVID burnout accelerated departures from revenue cycle roles
• Experienced coders retiring faster than replacements entering

5.4 Data Fragmentation

• Average hospital uses 15+ disparate systems (EHR, PM, clearinghouse, payer portals)
• Lack of real-time eligibility/benefit verification at point of care
• Clinical documentation lives in EHR; billing data in PM system; payer rules on external portals
• No single source of truth connecting clinical, financial, and payer data

5.5 Misaligned Incentives

• Payers benefit financially from denials (float, write-offs)
• Payers face minimal penalties for inappropriate denials
• Provider appeals process is deliberately cumbersome
• CMS has been slow to enforce payer accountability

5.6 Legacy RCM Software Limitations

• Most RCM platforms are rules-based, not predictive
• Retrospective denial tracking vs. prospective denial prevention
• Batch processing vs. real-time intervention
• Limited NLP/AI capability for clinical documentation analysis

---

6. WILLINGNESS TO PAY SIGNALS

What Hospitals Pay Today

VC/PE Investment Activity (2023-2025)

Signal strength: The R1 RCM acquisition at $8.9B and Waystar IPO at ~$3.7B market cap on listing day demonstrate massive PE/public market appetite. Multiple AI-native startups raising $50M-$120M rounds specifically for denial management signals strong WTP for next-gen solutions.

---

7. MARKET GROWTH RATE

Key growth drivers:

• Regulatory complexity increasing (No Surprises Act, prior auth reform)
• Labor shortages forcing automation adoption
• Medicare Advantage enrollment growth (more complex payer mix)
• AI/ML maturation enabling predictive denial prevention
• CMS interoperability mandates creating data availability

---

8. KEY PLAYERS TODAY

Major RCM / Denial Management Companies

AI-Native Disruptors

---

9. KEY SOURCES

All sources referenced in this report. Note: URLs are provided as best-known links; some may require subscription access.

Industry Associations and Government

1. HFMA (Healthcare Financial Management Association) - Denial benchmarking reports and workforce surveys
   • https://www.hfma.org/topics/financial-sustainability/
2. KFF (Kaiser Family Foundation) - Medicare Advantage denial data
   • https://www.kff.org/medicare/issue-brief/over-35-million-prior-authorization-requests-were-submitted-to-medicare-advantage-plans-in-2021/
3. CMS National Health Expenditure Data - Total healthcare spending
   • https://www.cms.gov/data-research/statistics-trends-and-reports/national-health-expenditure-data
4. OIG (HHS Office of Inspector General) - MA denial investigations
   • https://oig.hhs.gov/reports/
5. AHA (American Hospital Association) - Hospital statistics
   • https://www.aha.org/statistics
6. CAQH Index - Claims volume and automation data
   • https://www.caqh.org/explorations/caqh-index

Market Research Firms

1. Grand View Research - RCM market analysis
   • https://www.grandviewresearch.com/industry-analysis/revenue-cycle-management-market
2. Fortune Business Insights - RCM market forecast
   • https://www.fortunebusinessinsights.com/revenue-cycle-management-market-103045
3. Polaris Market Research - Medical billing outsourcing
   • https://www.polarismarketresearch.com/industry-analysis/medical-billing-outsourcing-market
4. Allied Market Research - Denial management market
   • https://www.alliedmarketresearch.com/
5. Market Research Future - Healthcare RCM
   • https://www.marketresearchfuture.com/

Industry Publications and Data

1. Change Healthcare / Optum Revenue Cycle Index - Denial rate trends and cost-to-appeal data
   • https://www.changehealthcare.com/insights/revenue-cycle-denials-index
2. Experian Health - State of Claims survey (2024)
   • https://www.experian.com/healthcare/
3. Becker's Hospital Review - RCM workforce and spending
   • https://www.beckershospitalreview.com/finance/
4. Fierce Healthcare - Denial rate trends
   • https://www.fiercehealthcare.com/finance
5. KLAS Research - RCM software vendor ratings
   • https://klasresearch.com/
6. Advisory Board (Optum) - Denial management analytics
   • https://www.advisory.com/topics/revenue-cycle-management
7. Premier Inc. - Denial analytics and benchmarking
   • https://www.premierinc.com/
8. AAPC - Coding workforce and salary data
   • https://www.aapc.com/
9. MGMA - Practice management benchmarks
   • https://www.mgma.com/

Deal / Investment Sources

1. Waystar S-1 / IPO Filing - SEC Edgar
   • https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&company=waystar
2. R1 RCM Take-Private - Press coverage
   • https://www.beckershospitalreview.com/finance/r1-rcm-acquired-for-8-9b.html
3. AKASA Funding - Crunchbase / press releases
   • https://www.akasa.com/

---

EXECUTIVE SUMMARY

The US insurance claim denial management problem represents one of the largest inefficiencies in healthcare:

• $150B-$225B in hospital revenue is initially denied annually
• $20B-$45B is permanently written off, with 50-65% of denials never even appealed
• When hospitals do appeal, they win 50-70% of the time -- revealing a massive recoverable revenue pool abandoned due to operational constraints
• Hospitals spend $20B+ annually on denial management through a combination of in-house staff, outsourced services, and technology
• The RCM market is growing at 10-13% CAGR with AI-specific sub-segments growing at 20-25%
• PE/VC conviction is high: R1 RCM acquired for $8.9B, Waystar IPO at ~$3.7B, and $200M+ deployed into AI-native denial management startups in 2023-2024

The problem persists because it is structurally adversarial (payers benefit from denials), operationally complex (72,000 ICD-10 codes, constantly changing payer rules), and plagued by workforce challenges (25-40% coder turnover). Legacy RCM tools are rules-based and retrospective. The market is ripe for AI-native solutions that can predict denials before submission, auto-generate appeals, and adapt in real-time to payer algorithm changes.

Largest opportunity vector: Converting the 50-65% of denials that are currently abandoned into appealed and recovered revenue using AI-powered automation. At a 60% appeal success rate, this represents $6B-$16B in recoverable revenue annually -- a value proposition that can support premium SaaS pricing.